AbbVie dumps an early-stage drug in $225M Alzheimer's alliance with Alector – Endpoints News

Business News

1. AbbVie dumps an early-stage drug in $225M Alzheimer’s alliance with Alector  Endpoints News
2. AbbVie dumps Alector’s Alzheimer’s immunotherapy after phase 1 review  FierceBiotech

Source: Business News